HAVN Life Sciences Inc. (HAVLF)

USD 0.01

(0.0%)

Market Cap (In USD)

537.33 Thousand

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

392.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.09567
PE
-
EPS
-
Beta Value
-0.649
ISIN
CA4196213058
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Tim Moore
Employee Count
-
Website
https://www.havnlife.com
Ipo Date
2021-01-08
Details
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.